Krishna Institute of Medical Sciences Limited posted its results for the quarter and nine months ended December 2021 and has recorded satisfactory growth during the period.
It reported consolidated revenue of Rs393.57 crore for the quarter ended December 2021, as compared to Rs360.66 crore for the previous corresponding quarter, registering a growth of 9.13% yoy.
Company’s PBT for the quarter under review stood at Rs112.35 crore as against Rs64.52 crore for the previous corresponding quarter, up by 74% yoy. Its PAT for the December 2021 quarter was reported at Rs84.19 crore as compared to Rs47.78 crore for December 2020 quarter, up by 76% yoy.
Its consolidated revenue for the nine months ended December 2021 stood at Rs1278.49 crore against Rs971.40 crore for the previous nine months period, up by 31% yoy.
Consolidate PAT for nine months jumped by 77.36% yoy at Rs260.47 crore as compared to Rs971.40 crore for the nine months ended December 2020.
Krishna Institute ended 2.90% higher at Rs1,325 against its previous closing price of Rs1,287.60. It touched the intraday high and low of Rs1,332 and Rs1,279.30 respectively.
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.